Life Sciences

Researchers have identified practical tools to detect progerin—a protein that causes Hutchinson-Gilford Progeria Syndrome, a rare genetic disorder of rapid aging—and measure resulting cardiac damage. The discovery could enable earlier intervention and improve clinical trials for this devastating childhood condition.EN

Researchers have updated evidence on the biological factors underlying suicidal behavior, potentially opening pathways for earlier intervention and prevention. The findings could help clinicians identify high-risk individuals before crisis points, reducing costs to healthcare systems and saving lives.EN

A decade-old technique called Hi-C, which reveals how DNA folds inside cells, catalyzed an entirely new field of study that's reshaping understanding of gene regulation and disease. The breakthrough has opened commercial opportunities in drug discovery, diagnostics, and synthetic biology as companies race to translate 3D genome insights into practical applications.EN

Researchers have mapped the structural details of how cells assemble mitochondrial ribosomes—the machinery that produces proteins inside mitochondria. The findings could unlock new drug targets and explain why certain genetic diseases strike unexpectedly, with implications for antibiotic development and mitochondrial disease treatments.EN

A major review finds that neurodevelopmental conditions like autism and ADHD present differently in males and females, yet diagnostic criteria and treatments remain skewed toward male presentations. This oversight delays diagnoses in girls and women by years, affecting school performance, employment, and clinical trial design—forcing healthcare systems and pharmaceutical companies to reckon with entrenched gender blindness.EN

Researchers discovered that PCYT2, a gene regulating fat production in cells, is crucial for maintaining muscle health and slowing age-related decline. The finding could unlock new drug targets for treating muscle wasting—a costly condition affecting elderly patients and a growing public health concern as populations age worldwide.EN

Researchers used single-molecule imaging to reveal how different COVID-19 spike variants bind to human ACE2 receptors with varying strength, a finding that could guide vaccine design and help predict which variants pose the greatest infection risk. Understanding these molecular mechanics may enable faster responses to future coronavirus threats.EN

Researchers discovered that transplanted neural stem cells that die in the injured brain actually accelerate healing in surrounding tissue through a "bystander effect." The finding could reshape how scientists design cell therapies for stroke and traumatic brain injury, potentially improving outcomes without requiring cells to survive long-term.EN

Researchers have revised the official taxonomy of apoptotic cell death—a fundamental process in diseases from cancer to neurodegeneration—for the first time since 2018. The update could accelerate drug development by clarifying how cells actually fail in disease, helping companies and clinicians target the right mechanisms.EN

Researchers have identified how CRISPR gene-editing tools cause unintended DNA breaks, a critical safety concern for therapies moving toward clinical use. The finding could guide development of safer editing approaches and influence regulatory decisions for CRISPR-based medicines entering the market.EN

Researchers have decoded the communication between nociceptors (pain-sensing nerves) and dendritic cells (immune coordinators), revealing a previously unknown dialogue that shapes immune response. The discovery could open new pathways for treating inflammatory diseases and chronic pain—two conditions that drive billions in healthcare spending globally.EN

Researchers have outlined evidence-based approaches for treating and preventing mpox in two vulnerable populations—pregnant people and young children—where standard treatments carry unknown risks. The guidance matters for public health agencies and healthcare systems preparing contingency protocols for future outbreaks.EN

Levande cancerterapier baserade på bakterier, virus och mikrobiom öppnar nya vägar för urinblåsecancer där konventionella behandlingar misslyckas. Framför allt BCG och utvalda onkolytiska virusplattformar har uppnått klinisk tillämpning, men behovet av effektivare strategier för BCG-resistenta patienter är brådskande. Recensionen identifierar fem överlappande mekanismer: direkt tumördödsfall genom bakteriell kolonisering, immunaktivering, programmerad läkemedelsleverans via genetisk konstruering, virusmedierad tumörlysis och mikrobiommodulering. Dessa oncobiotics kan överkomma begränsningar hos befintliga terapi genom att utnyttja blåsans tillgänglighet för lokal behandling. Institutioner som Sahlgrenska och University of Gothenburg bidrar till denna utveckling. Även om de mest avancerade systemen fortfarande befinner sig i preklinisk fas, accelererar framsteg inom syntetisk biologi utvecklingen. FoU-investerare bör notera att detta område erbjuder möjligheter för tidig positionering innan regulatoriska vägar etableras.

**Akustisk övervakning avslöjar neonikotinoid-skador på myror redan under miljöreleveanta doser** Metod för att tidigt detektera pesticidbuskador på mark-levande insekter har saknats. Svenska forskare vid Umeå universitet demonstrerar att ljudinspelningar kan avslöja subletala beteendeförändringar i rödmyrkoloniers (Formica rufa) aktivitet orsakade av imidakloprid. Kolonier exponerade för miljöreleveanta imidaklopridhalter (10,8 ± 5,7 ng g⁻¹) visade ökad aktivitet inom sex timmar, följt av långsam återhämtning över en vecka. Metoden lyckades upptäcka denna långtidseffekt trots myrornas underjordiska miljö — något andra tekniker missat. Forskargruppen inkluderade Svenska lantbruksuniversitetet, NORCE Research AS och Species360. Akustisk övervakning möjliggör icke-invasiv fältövervakning av skadliga effekter och kan bli ett verktyg för regulatorisk miljötestning av kemikalier. Resultaten väcker frågor om neonikotinoidernas påverkan på pollinerare och markekosystem vid låga expositionsnivåer.

Researchers identified molecular signals in tiny particles circulating in blood that prepare distant organs to receive cancer cells—a process called pre-metastatic niche formation. The discovery could enable earlier detection of patients at high relapse risk after surgery and potentially lead to therapies that block metastasis before it starts.EN

Researchers have developed a virtual testing environment that lets manufacturers safely evaluate how robots and human workers interact before deploying them on real factory floors. The platform cuts development time and liability risk, potentially accelerating adoption of collaborative robotics in warehouses and production facilities worldwide.EN

Scientists discovered that two genes linked to aggressive blood cancers produce alternative protein versions controlled by hidden internal promoters—a finding that could enable earlier AML detection and improve diagnosis across multiple cancer types. The tissue-specific patterns suggest these protein variants may serve as reliable biomarkers for identifying which patients face the poorest prognosis.EN

Researchers discovered that mezigdomide can restore exhausted T cells—immune soldiers that lose fighting power against cancer—by targeting two key proteins that shut down their activity. The finding could overcome a major barrier limiting the effectiveness of immunotherapies in multiple myeloma, potentially expanding treatment options for patients who develop resistance.EN

Researchers propose the cerebellum controls walking through simple, hardwired neural architecture rather than learning—overturning decades of mainstream neuroscience. The finding could reshape how companies develop brain-computer interfaces, prosthetics, and neuromorphic AI systems, potentially unlocking cheaper, more efficient designs based on biological principles overlooked for years.EN

Researchers are advancing CAR-T cells, oncolytic viruses, and engineered bacteria as cancer treatments that fight tumors while boosting immune response. While these approaches show real promise in blood cancers, solid tumors remain difficult to treat—a bottleneck that will determine whether biotech companies can expand these therapies into blockbuster markets.EN

Scientists are developing new treatments targeting astrocytes—support cells in the brain—to address neurological conditions. The work could open a significant new market for brain therapies and reshape how neurological diseases are treated clinically.EN

Researchers developed a platelet-coated nanoparticle that delivers clot-busting drugs more safely and effectively in stroke models, potentially addressing the narrow therapeutic window that restricts current FDA-approved treatments. The approach reduced bleeding complications while improving blood flow recovery—key barriers that could expand treatment eligibility and reshape the stroke care market if human trials succeed.EN

Researchers have developed a carbon nanotube-based hydrogel that can reliably record brain activity from inside the ear canal, potentially creating a new category of discreet wearable neurotechnology. The advance could enable continuous monitoring of infants, elderly patients, and others who cannot tolerate traditional headsets, opening a significant market for brain-computer interfaces and clinical diagnostics.EN

Researchers combined deep learning with retrobiosynthesis to systematically catalog how yeast cells convert chemicals—uncovering metabolic routes that standard methods miss. The advance could accelerate development of engineered microbes for biomanufacturing drugs, fuels, and specialty chemicals at lower cost.EN

Researchers propose combining blood biopsies with genetic mutation analysis to catch tumors earlier and match patients to treatments more precisely. The approach could unlock personalized cancer care for patients whose tumors lack known drug targets—potentially opening new markets for diagnostics and expanding treatment options across solid tumors.EN